SGLT2 inhibition may reduce myocardial extracellular volume

January 15, 2021

… (ECV) among individuals with type 2 diabetes and coronary artery disease, suggests an analysis of data from the EMPA-HEART CardioLink-6 trial.

Read more at www.medwirenews.com

January 15, 2021

Read Next

September 30, 2023

NAU launches College of Medicine to address primary care physician shortage – AZ Family

September 30, 2023

Toronto doctor who kept licence despite sexually abusing patients is suspended for third time

September 30, 2023

Yearly attained adherence to Mediterranean diet and incidence of diabetes in a large …

September 30, 2023

Using Trusted Community Networks to Vaccinate Older Persons Against COVID-19 – JSI

September 30, 2023

New Two-Tier System to Weed Out Some Pediatric Heart Surgery Centers | MedPage Today